Trends in Invasive Pneumococcal Disease--Associated Hospitalizations, Clinical Infectious Diseases, vol.42, issue.1, pp.1-5, 2006. ,
DOI : 10.1086/498745
Epidemiology of Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Infections in the United States, 1995-1998<SUBTITLE>Opportunities for Prevention in the Conjugate Vaccine Era</SUBTITLE>, JAMA, vol.285, issue.13, pp.1729-1735, 1995. ,
DOI : 10.1001/jama.285.13.1729
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.1303-1310, 2001. ,
DOI : 10.1097/00003246-200107000-00002
Community-Acquired Pneumonia Requiring Admission to an Intensive Care Unit, Medicine, vol.86, issue.2, pp.103-111, 2007. ,
DOI : 10.1097/MD.0b013e3180421c16
URL : http://doi.org/10.1097/md.0b013e3180421c16
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis, Intensive Care Medicine, vol.299, issue.suppl, pp.222-231, 2010. ,
DOI : 10.1007/s00134-009-1738-3
Decrease in Long-term Survival for Hospitalized Patients With Community-Acquired Pneumonia, Chest, vol.138, issue.2, pp.279-283, 2010. ,
DOI : 10.1378/chest.09-2702
Burden of Community-Acquired Pneumonia in North American Adults, Postgraduate Medicine, vol.26, issue.44, pp.130-141, 2010. ,
DOI : 10.1378/chest.121.1.264
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia, Intensive Care Medicine, vol.47, issue.Suppl 9A, pp.612-620, 2010. ,
DOI : 10.1007/s00134-009-1730-y
Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia, Intensive Care Medicine, vol.25, issue.2, pp.198-206, 1999. ,
DOI : 10.1007/s001340050816
Severe Community-acquired Pneumococcal Pneumonia, Scandinavian Journal of Infectious Diseases, vol.22, issue.3, pp.201-206, 1995. ,
DOI : 10.7326/0003-4819-115-6-428
Adjunctive Therapy in Community-Acquired Pneumonia, Seminars in Respiratory and Critical Care Medicine, vol.30, issue.02, pp.146-153, 2009. ,
DOI : 10.1055/s-0029-1202933
Pathogenesis, treatment, and prevention of pneumococcal pneumonia, The Lancet, vol.374, issue.9700, pp.1543-1556, 2009. ,
DOI : 10.1016/S0140-6736(09)61114-4
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention ,
Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.158, issue.4, pp.1102-1108, 1998. ,
DOI : 10.1164/ajrccm.158.4.9803114
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM Consensus Conference Committee, p.28, 1992. ,
DOI : 10.1378/chest.101.6.1644
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination., American Journal of Respiratory and Critical Care Medicine, vol.149, issue.3, pp.818-824, 1994. ,
DOI : 10.1164/ajrccm.149.3.7509706
Acute renal failure definition , outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Critical Care, vol.8, issue.4, pp.204-212, 2004. ,
DOI : 10.1186/cc2872
The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group, JAMA: The Journal of the American Medical Association, vol.276, issue.10, pp.802-810, 1996. ,
DOI : 10.1001/jama.276.10.802
A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-2963, 1993. ,
DOI : 10.1001/jama.1993.03510240069035
Cigarette Smoking and Invasive Pneumococcal Disease, New England Journal of Medicine, vol.342, issue.10, pp.681-689, 2000. ,
DOI : 10.1056/NEJM200003093421002
Association of gender with outcomes in critically ill patients, Critical Care, vol.16, issue.3, p.92, 2012. ,
DOI : 10.1097/01.CCM.0000190242.24410.17
Does gender influence outcomes in critically ill patients? Crit Care, p.129, 2012. ,
Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough, Intensive Care Medicine, vol.133, issue.3, pp.430-438, 2009. ,
DOI : 10.1007/s00134-008-1363-6
Early mortality in patients with community-acquired pneumonia: causes and risk factors, European Respiratory Journal, vol.32, issue.3, pp.733-739, 2008. ,
DOI : 10.1183/09031936.00128107
A Comparison of Bacteremic Pneumococcal Pneumonia with Nonbacteremic Community-Acquired Pneumonia of Any Etiology ??? Results from a Canadian Multicenter Study, Canadian Respiratory Journal, vol.10, issue.7, pp.368-374, 2003. ,
DOI : 10.1155/2003/862856
The Presence of Pneumococcal Bacteremia Does Not Influence Clinical Outcomes in Patients With Community-Acquired Pneumonia, Chest, vol.133, issue.3, pp.618-624, 2008. ,
DOI : 10.1378/chest.07-1322
consensus guidelines on the management of community-acquired pneumonia in adults, Infectious Diseases Society of America Clin Infect Dis, issue.2, pp.44-71, 2007. ,
Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes, Thorax, vol.65, issue.1, pp.77-81, 2010. ,
DOI : 10.1136/thx.2009.123612
URL : http://hdl.handle.net/2445/49275
Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*, Critical Care Medicine, vol.33, issue.5, pp.952-961, 2005. ,
DOI : 10.1097/01.CCM.0000162381.24074.D7
Drotrecogin alfa (activated) ... a sad final fizzle to a roller-coaster party, Critical Care, vol.16, issue.1, p.107, 2012. ,
DOI : 10.1056/NEJMoa050935
Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.11, pp.1561-1568, 2011. ,
DOI : 10.1164/rccm.201007-1167OC
Hydrocortisone Infusion for Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.3, pp.242-248, 2005. ,
DOI : 10.1164/rccm.200406-808OC
Efficacy of Corticosteroids in Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.9, pp.975-982, 2010. ,
DOI : 10.1164/rccm.200905-0808OC
Hydrocortisone Therapy for Patients with Septic Shock, New England Journal of Medicine, vol.358, issue.2, pp.111-124, 2008. ,
DOI : 10.1056/NEJMoa071366
Impact of intravenous ??-lactam/macrolide versus ??-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia, Journal of Antimicrobial Chemotherapy, vol.63, issue.5, pp.1025-1033, 2009. ,
DOI : 10.1093/jac/dkp088
Addition of a Macrolide to a ?????Lactam???Based Empirical Antibiotic Regimen Is Associated with Lower In???Hospital Mortality for Patients with Bacteremic Pneumococcal Pneumonia, Clinical Infectious Diseases, vol.36, issue.4, pp.389-395, 2003. ,
DOI : 10.1086/367541
Monotherapy May Be Suboptimal for Severe Bacteremic Pneumococcal Pneumonia, Archives of Internal Medicine, vol.161, issue.15, pp.1837-1842, 2001. ,
DOI : 10.1001/archinte.161.15.1837
Pneumonia in Adults, Canadian Respiratory Journal, vol.11, issue.8, pp.589-593, 2004. ,
DOI : 10.1155/2004/461392
Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.4, pp.440-444, 2004. ,
DOI : 10.1164/rccm.200311-1578OC
Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock*, Critical Care Medicine, vol.35, issue.6, pp.1493-1498, 2007. ,
DOI : 10.1097/01.CCM.0000266755.75844.05
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia, European Respiratory Journal, vol.33, issue.1, pp.153-159, 2009. ,
DOI : 10.1183/09031936.00054108
Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia, European Journal of Clinical Microbiology & Infectious Diseases, vol.44, issue.Suppl 2 ,
DOI : 10.1007/s10096-007-0307-3
Addition of a macrolide to a ??-lactam in bacteremic pneumococcal pneumonia, European Journal of Clinical Microbiology & Infectious Diseases, vol.46, issue.Suppl 1A, pp.518-521, 2006. ,
DOI : 10.1007/s10096-006-0183-2
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia, European Respiratory Journal, vol.27, pp.1010-1019, 2006. ,
DOI : 10.1183/09031936.06.00126004
Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia, Clinical Therapeutics, vol.22, issue.7, pp.872-878, 2000. ,
DOI : 10.1016/S0149-2918(00)80059-4
The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis, European Respiratory Journal, vol.30, issue.3, pp.525-531, 2007. ,
DOI : 10.1183/09031936.00031007
Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis, European Journal of Clinical Microbiology & Infectious Diseases, vol.40, issue.10, pp.688-690, 2005. ,
DOI : 10.1007/s10096-005-0018-6
Seasonal Patterns of Invasive Pneumococcal Disease, Emerging Infectious Diseases, vol.9, issue.5, pp.573-579, 2003. ,
DOI : 10.3201/eid0905.020556
Seasonality of invasive pneumococcal disease: Temporal relation to documented influenza and respiratory syncytial viral circulation, The American Journal of Medicine, vol.118, issue.3, pp.285-291, 2005. ,
DOI : 10.1016/j.amjmed.2004.09.016
Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, Spain, New England Journal of Medicine, vol.333, issue.8, pp.474-480, 1995. ,
DOI : 10.1056/NEJM199508243330802
Drug???Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors, Clinical Infectious Diseases, vol.38, issue.6, pp.787-798, 2004. ,
DOI : 10.1086/381886
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Critical Care Medicine, vol.34, issue.6, pp.1589-1596, 2006. ,
DOI : 10.1097/01.CCM.0000217961.75225.E9
Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia, Thorax, vol.64, issue.7, pp.598-603, 2009. ,
DOI : 10.1136/thx.2009.113795
Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia, European Respiratory Journal, vol.36, issue.5, pp.1073-1079, 2010. ,
DOI : 10.1183/09031936.00176309
The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy, Critical Care, vol.12, issue.Suppl 6, p.5, 2008. ,
DOI : 10.1186/cc7028
Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis, The Lancet Infectious Diseases, vol.9, issue.1, pp.31-44, 2009. ,
DOI : 10.1016/S1473-3099(08)70261-5